Latest Videos

What are you doing in terms of continuation of oral anticoagulation during the procedure? – Professor Jan Steffel

15 Dec 2021

Dr Jan Steffel MD FESC FEHRA FHRS: Professor and Vice Chairman of the Department of Cardiology, Senior Consultant, Division of Electrophysiology & Cardiac Devices,...

Video

Advancing cardiac diagnostics during COVID-19: Improving Hospital Efficiency & Safety with ICMs

11 Oct 2021

Chairperson: Prof. Thorsten Lewalter – Professor of Internal Medicine – Cardiology, University of Bonn; Head. Dept. of Cardiology and Intensive Care, Peter...

Video

What role does the procedural or clinical complexity have in the decision of antithrombotic therapy? – Professor Jan Steffel

01 Sep 2021

Dr Jan Steffel MD FESC FEHRA FHRS: Professor and Vice Chairman of the Department of Cardiology, Senior Consultant, Division of Electrophysiology & Cardiac Devices,...

Video

What do guidelines say for the post PCI antithrombotic therapy and are there differences between the US and EU? – Professor Jan Steffel

01 Sep 2021

Dr Jan Steffel MD FESC FEHRA FHRS: Professor and Vice Chairman of the Department of Cardiology, Senior Consultant, Division of Electrophysiology & Cardiac Devices,...

Video

Shall the OAC be continued or stopped during PCI – What do the clinical trials say? – Professor Jan Steffel

01 Sep 2021

 Dr Jan Steffel MD FESC FEHRA FHRS: Professor and Vice Chairman of the Department of Cardiology, Senior Consultant, Division of Electrophysiology & Cardiac...

Video

NOACs in patients with atrial fibrillation: Insights from the cardiac cath lab – ESC Congress 2020: The Digital Experience

29 Nov 2020

Chairpersons John William Eikelboom (Hamilton, Canada) Dominick Joseph Angiolillo (Jacksonville, United States of America) Subtitle Sponsored by Boehringer Ingelheim...

Video

Atrial fibrillation patients in focus: clinical cases and guidelines – ESC Congress 2020: The Digital Experience

29 Oct 2020

 Chairpersons Gregory Yh Lip (Liverpool, United Kingdom of Great Britain & Northern Ireland) Elaine Hylek (Boston, United States of America) Subtitle Sponsored by...

Video

What do we know about the 4 available post PCI studies and how could the guidelines take them into account? – Professor Jan Steffel

19 Oct 2020

Dr Jan Steffel MD FESC FEHRA FHRS: Professor and Vice Chairman of the Department of Cardiology, Senior Consultant, Division of Electrophysiology & Cardiac Devices,...

Video

Dual versus triple antithrombotic therapy post PCI – what do the guidelines say, are there any similarities & differences between North America and EU? – Professor Jan Steffel

12 Oct 2020

Dr Jan Steffel MD FESC FEHRA FHRS: Professor and Vice Chairman of the Department of Cardiology, Senior Consultant, Division of Electrophysiology & Cardiac Devices,...

Video

Dual versus triple antithrombotic therapy post PCI – What does the data with NOACs say? – Professor Jan Steffel

01 Jun 2020

Dr Jan Steffel MD FESC FEHRA FHRS: Professor and Vice Chairman of the Department of Cardiology, Senior Consultant, Division of Electrophysiology & Cardiac Devices,...

Video

10 years since RE-LY: comprehensive experience for atrial fibrillation patients – ESC 2019

16 Mar 2020

Chairpersons: John William Eikelboom (Hamilton, Canada), Gregory Yh Lip Liverpool, United Kingdom) Subtitle: Sponsored by Boehringer Ingelheim Learning Objectives: To...

Video

NOACs in patients undergoing cardiac procedures – ESC 2019

16 Mar 2020

Chairpersons: Christopher Paul Cannon (Boston, United States of America), Dominick Joseph Angiolillo (Jacksonville, United States of America) Subtitle: Sponsored by...

Video

What do we know about dabigatran in elderly patients?

01 Oct 2019

Based on the patient characteristics of an elderly AF patient with renal impairment Dr. John W. Eikelboom will review existing data from multiple sources including...

Video

What do we know about dabigatran in patients with cardiovascular disease?

01 Oct 2019

Based on the patient characteristics of an AF patient with cardiovascular comorbidities Dr. John W. Eikelboom will review existing data from multiple sources including...

Video

Dabigatran, a direct thrombin inhibitor, reduces the risk of an intracerebral haemorrhage: Protection of the blood brain barrier

01 Oct 2019

This is a video showing the MOA of thrombin inhibition on  intracranial haemorrhage. It shows how dabigatran, a thrombin inhibitor minimises thrombin mediated damage...

Video

RE-DUAL PCI Congress Presentation and Q&A

01 Oct 2019

Congress Presentation presented at AHA 2017 given by Dr. Chris Cannon with slides on a neutral background ( only Study branding) Including Q&A with Dr. Cannon and...

Video

Reversibility of NOAC therapies: the neurologist’s perspective – Prof. Dr. Martin Grond

01 Oct 2019

Neurologist’s Perspective of Reversal for Thrombolysis or ICH with Prof. Dr. Martin GrondThis adaptable 6 min video presents neurology cases from real clinical...

Video

The RE-LY Trial – A landmark study in cardiology

01 Oct 2019

Communicate RE-LY data including subgroups data and leverage expert opinion from Dr. John W. Eikelboom to cover: Overview of safety/efficacy profile established in...

Video

Interview with Oscar Oseroff, Secretary General: World Society of Arrhythmias

19 Sep 2019

Interview with Oscar Oseroff, Secretary General: World Society of Arrhythmias. In this interview he invites fellow friends and colleagues to join him at the World...

Video

Dual antithrombotic therapy with Dabigatran in AF patients post PCI – Expert interview with Dr. Jur ten Berg

10 May 2019

Expert interview with Dr. Jur ten Berg about dual antithrombotic therapy with Dabigatran in AF patients post PCI. In the interview he focuses mainly on new subanalyses,...

Dual antithrombotic therapy with Dabigatran in AF patients post PCI – Professor Stefan Hohnloser

09 May 2019

Interview series with Professor Stefan Hohnloser about dual antithrombotic therapy with Dabigatran in AF patients post PCI Should dabigatran dual therapy be the default...

New Insights Into Post-PCI Care: The Re-Dual PCI Study

09 May 2019

Dr. Dominick Angiolillo summarizes the results of the RE-DUAL PCI study showing the safety of dabigatran dual therapy post-PCI with doses approved for stroke prevention...

Changing Clinical Practice The Re-Circuit Study

08 May 2019

In the video Dr. Gupta summarized the results of the RE-CIRCUIT study confirming the safety profile of dabigatran also in the setting of catheter ablation in AF...

RE-CIRCUIT Study of Peri-Procedural Anticoagulation in AF Ablation

08 May 2019

An infographic publication video summarizing the results of the RE-CIRCUIT study recently published in NEJM comprehensively in less than 2...

GLORIA-AF Final Phase II Two-year safety and effectiveness of dabigatran in AF patients (GYH Lip)

08 May 2019

Summary of GLORIA-AF Final Phase II: Two-year safety and effectiveness of dabigatran in patients with atrial fibrillation (summarized by Prof Gregory Lip). An...

From Clinical trials to RWE infographic animation (version with RE-LY EU label analysis)

03 May 2019

The series of infographic animations communicate the consistency of results, how RWE supports the favorable safety profile and the importance of RWE evidence. From...